[Observation on the therapeutic effect of Lamivudin on chronic hepatitis B].

Objective: To observe the therapeutic effect of Lamivudine on controlling hepatitis B virus DNA replication.

Methods: The liver disease patients were divided into two groups, the treated group (n=64) was given Lamivudine 100 mg once a day for one year and was additionally given liver protection drugs according to their liver function, while the control group (n=30) was given common liver protection drugs. The blood routine test, liver function and the viral markers were detected at defined times.